Package 58657-500-04

{"route": ["ORAL"], "spl_id": "41b41a1f-2e84-3be6-e063-6294a90a888d", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["GSL05Y1MN6", "495W7451VQ"], "rxcui": ["995868"], "spl_set_id": ["fe126254-6ee6-48c3-965c-96e4276a5314"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Method Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 mL in 1 BOTTLE (58657-500-04)", "package_ndc": "58657-500-04", "marketing_start_date": "20140401"}, {"sample": false, "description": "473 mL in 1 BOTTLE (58657-500-16)", "package_ndc": "58657-500-16", "marketing_start_date": "20140401"}], "brand_name": "Codeine-Guaifenesin", "product_id": "58657-500_41b41a1f-2e84-3be6-e063-6294a90a888d", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Full Opioid Agonists [MoA]", "Increased Respiratory Secretions [PE]", "Opioid Agonist [EPC]"], "product_ndc": "58657-500", "dea_schedule": "CIII", "generic_name": "Codeine Phosphate and Guaifenesin", "labeler_name": "Method Pharmaceuticals, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Codeine-Guaifenesin", "active_ingredients": [{"name": "CODEINE PHOSPHATE", "strength": "10 mg/5mL"}, {"name": "GUAIFENESIN", "strength": "100 mg/5mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20140401", "listing_expiration_date": "20261231"}